Buy an Oncology Practice: Financing a Community Cancer Practice
For an oncologist who wants to stay independent, the decision to buy an oncology practice can be a way to own a community cancer program without building one from scratch. An established practice brings an existing patient base, referral relationships, trained infusion nurses, payer contracts and a location patients already trust.
It is also one of the more complex acquisitions in medicine. Oncology practices often carry large drug inventories, significant equipment and revenue that depends heavily on Medicare and drug reimbursement. This guide explains what buyers should evaluate and how acquisitions are typically financed. Ownership, licensing and reimbursement rules vary by state and payer, and nothing here is legal, tax, billing or compliance advice.
Why Buyers Are Looking at Community Oncology
Many independent oncology practices are weighing their future. Some owners are approaching retirement, some are fielding offers from hospitals or private equity groups, and some would prefer to hand the practice to a physician who will keep it independent.
For a buyer, that creates opportunity, but also competition. Hospitals and larger networks may offer sellers different terms than an individual physician can. A well-prepared buyer with financing lined up can be a credible alternative, especially for sellers who care about continuity for patients and staff.
Understand How the Practice Earns Revenue
Oncology revenue looks different from most specialties. A large share often comes from drugs administered in the office, which the practice purchases in advance and bills to payers afterward. Buyers should separate revenue into its main sources:
- Professional services: office visits, consultations and care management
- Drug revenue: infused and injected therapies purchased and billed by the practice
- Ancillaries: laboratory, imaging, radiation or dispensing services, where present
- Value-based or program payments: which may vary from year to year
Drug revenue can be large, but the margin on it may be much smaller than the gross figure suggests. Understanding the true contribution of each line matters more than the top-line number. Our guide to oncology practice valuation explains how drug revenue, payers and earnings affect price.
Review Payer Mix and Reimbursement Exposure
Many oncology practices treat a large share of Medicare patients, and changes in drug reimbursement rules or physician fee schedules can affect cash flow. Buyers should review revenue by payer over several years, how promptly claims are paid and whether any single commercial insurer represents an outsized share.
Payer contracts, Medicare and Medicaid enrollments and credentialing should not be assumed to transfer to a new owner. Depending on the deal structure, the buyer may need to update enrollments or sign new agreements, and claims may be delayed while that work is completed. Healthcare counsel and qualified billing professionals can help plan the change of ownership.
Evaluate Owner Dependence and the Clinical Team
In a smaller practice, the selling oncologist may see a large share of patients and hold key referral relationships with surgeons, primary care physicians and hospitals. If that physician leaves quickly, patient volume may drop.
Buyers should review:
- How many patients the seller personally manages
- Whether other physicians and advanced practice providers will stay
- Infusion nursing and pharmacy staff tenure and certifications
- Employment agreements and restrictive covenants, which should be reviewed by counsel because enforceability varies by state
- How workers are classified, which should be reviewed by qualified professionals
A documented seller transition period can help keep patients and referral sources in place.
Plan for Drug Inventory and Working Capital
Buy-and-bill purchasing means the practice pays for many drugs before it is reimbursed. A buyer may need to fund inventory at closing and carry receivables while enrollments are updated. Underestimating this gap is one of the most frequent mistakes in oncology acquisitions.
Our article on oncology buy-and-bill cash flow covers how practices finance drug purchases. Many buyers also arrange oncology working capital alongside the acquisition loan so the practice has room to operate during the transition.
How to Finance When You Buy an Oncology Practice
Most buyers use financing rather than paying the full price in cash. Depending on the transaction size and the buyer’s profile, options may include:
- SBA 7(a) loans: SBA 7(a) financing can be used toward a practice purchase, and in some cases working capital and related real estate. Eligibility and terms depend on the business, the buyer, use of proceeds, program rules and lender review.
- Conventional practice loans: lenders apply their own underwriting standards and may finance larger transactions for experienced buyers.
- Seller financing: a seller note may cover part of the price. Lenders and programs may limit seller notes and earnouts, and seller notes are typically subordinate to the senior lender.
Lenders generally review historical cash flow, the buyer’s clinical and management experience, credit history, available liquidity and the structure of the deal. Buyers should also plan for the equity injection; our guide to the oncology practice down payment explains how lenders think about it. Every loan is subject to approval, and nothing here is a commitment to lend.
Due Diligence Checklist
Before closing, buyers typically review:
- Tax returns, financial statements and bank statements
- Revenue by payer and by service line, including drug margin
- Drug inventory levels, purchasing arrangements and any group purchasing terms
- Accounts receivable aging and collection history
- Billing and documentation practices, reviewed by qualified billing or compliance professionals
- Equipment condition and existing leases or loans
- Real estate lease terms, assignment rights and landlord consent
- Licenses, insurance and any past audits or claims
Findings can change the price, the deal structure or whether the buyer moves forward.
Final Thoughts
Choosing to buy an oncology practice can preserve independent cancer care in a community while giving a physician ownership and control. The strongest acquisitions are built on a clear view of drug margin, payer exposure, owner dependence and working capital needs, with financing structured to fit the practice’s real cash flow.
US Medical Funding helps oncologists finance the purchase of established practices. Learn more about our oncology practice acquisition financing and our full range of oncology practice financing options.
